| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193653 | Annals of Allergy, Asthma & Immunology | 2006 | 10 Pages |
Abstract
Both IVIG and cyclosporine have been associated with enhanced healing and better survival through inhibition of apoptosis. Multicenter, randomized, placebo-controlled trials using a standardized design are needed to validate these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Khalili Barzin, Bahna Sami L.,